Powered by RND
PodcastsNewsMendelspod Podcast

Mendelspod Podcast

Theral Timpson
Mendelspod Podcast
Latest episode

Available Episodes

5 of 492
  • Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this episode of Mendelspod, Theral sits down with Rob Neely, co-founder and CSO at Tagomics, to discuss how his company is fusing genomics, epigenomics, and fragmentomics into a single, assumption-free assay for early cancer detection. The conversation begins with breaking news: Tagomics has just received a new grant from the UK’s Innovation Agency a…
    --------  
    4:53
  • From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this premium episode of Mendelspod, we’re joined by one of the few people speaking clearly and globally about biosecurity in the era of synthetic biology and AI: Sophie Peresson.A consultant and leader in responsible innovation, Sophie brings an unusually broad and grounded perspective. With experience spanning international law and governance, she p…
    --------  
    4:21
  • From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comAs artificial intelligence continues to influence the life sciences, some researchers are questioning not just what it can predict, but what it can explain. On this episode, Mike Kiebish, VP of Platform and Translational Sciences at BPGbio, discusses the company’s “biology-first” approach to drug discovery—one that begins not with models or literature, …
    --------  
    4:26
  • The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI
    In this episode of Mendelspod, we plunge into the shape-shifting world of RNA with Dr. Gavin Knott, associate professor at Monash University and alum of Jennifer Doudna’s lab. Knott is part of a new generation of researchers setting structural biology ablaze with AI, decoding RNA-guided systems and expanding the CRISPR toolbox far beyond its original scope.Knott introduces the listener to RNA not just as code, but as living language. He discusses how AI now allows scientists to see molecules in 3D at the beginning of a project rather than years into it: “You can take that protein sequence, run it through something like AlphaFold, and there it is, looking at you.”* 0:00 RNA - the shapeshifting paradox of a molecule* 4:05 Using AI: here’s an idea—maybe we know enough about biology* 6:50 The ARC Institute, and that one paper* 9:05 Structural biology at everyone’s fingertips* 18:10 Why are gene therapy companies going so slow?* 23:40 The grammar of RNAWith infectious curiosity, Knott explains how protein design is entering an era of intent, not just discovery. “Maybe we understand enough about the rules of biology,” he posits, “that we can design the proteins we need.” He describes his lab’s twin tracks: mining microbial genomes for novel RNA-guided machines and using generative AI tools like RosettaFold and BindSpace to build bespoke editors of DNA and RNA.The conversation touches on emerging efforts to mitigate off-target effects in gene editing using AI, the data limitations holding back RNA-protein modeling, and a powerful metaphor comparing static protein images to photos of horses.Knott makes a striking point: “We’ve known the spelling of RNA for a while, but now we’re trying to learn its grammar.” This, he explains, means understanding not just RNA’s sequence but its shape, movement, and silent punctuation marks—an effort he sees as the next frontier. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
    --------  
    31:29
  • The Third Way: Christian Schafmeister’s Spiroligomer Revolution
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comFor decades, drug discovery has followed two main roads: small molecules that can slip into cells but often lack precision, and biologics that offer specificity but struggle with delivery and manufacturing. In this episode, Christian Schafmeister introduces us to a third path: spiroligomers—synthetic, fused-ring molecules designed to combine the best of…
    --------  
    4:19

More News podcasts

About Mendelspod Podcast

Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine. www.mendelspod.com
Podcast website

Listen to Mendelspod Podcast, The Daily and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

Mendelspod Podcast: Podcasts in Family

Social
v7.20.2 | © 2007-2025 radio.de GmbH
Generated: 7/9/2025 - 9:40:18 AM